EXELA TECHNOLOGIES

(XELA)
  Report
Real-time Estimate Cboe BZX  -  08:56 2022-06-28 am EDT
0.1440 USD   +4.42%
07:00aExela Technologies Announces New Logo with L'Assurance Maladie Caisse Nationale, the French National Insurance Fund
AQ
06/22SECTOR UPDATE : Financial Shares Narrowly Higher Late
MT
06/22SECTOR UPDATE : Financial
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cantor Fitzgerald Adjusts Price Target on Exela Technologies to $2 From $4, Reiterates Overweight Rating

03/24/2022 | 07:05am EDT


© MT Newswires 2022
All news about EXELA TECHNOLOGIES
07:00aExela Technologies Announces New Logo with L'Assurance Maladie Caisse Nationale, the Fr..
AQ
06/22SECTOR UPDATE : Financial Shares Narrowly Higher Late
MT
06/22SECTOR UPDATE : Financial
MT
06/22Top Midday Gainers
MT
06/22Exela Technologies Secures New $136 Million Contract; Shares Climb
MT
06/22Exela Technologies Secures XBP Contract Totaling $136 Million
AQ
06/22Exela Technologies, Inc. Secures XBP Contract Totaling $136 Million
CI
06/21EXELA TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
06/21Exela Technologies Closes $150 Million Securitization Facility with PNC Bank
AQ
06/14Exela Technologies Names Lakshmi Narayanan Chandramohan President, Bills and Payments
AQ
More news
Analyst Recommendations on EXELA TECHNOLOGIES
More recommendations
Financials (USD)
Sales 2022 1 160 M - -
Net income 2022 -141 M - -
Net Debt 2022 1 077 M - -
P/E ratio 2022 -0,50x
Yield 2022 -
Capitalization 60,9 M 60,9 M -
EV / Sales 2022 0,98x
EV / Sales 2023 0,94x
Nbr of Employees 17 000
Free-Float -
Chart EXELA TECHNOLOGIES
Duration : Period :
Exela Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXELA TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,14 $
Average target price 1,18 $
Spread / Average Target 752%
EPS Revisions
Managers and Directors
Suresh Yannamani President
Shrikant Sortur Chief Financial Officer
Parvinder S. Chadha Executive Chairman
Sriram Ramanathan Chief Technology officer
John H. Rexford Independent Director